Inventor · disambiguated record
Dong-Xiao Zhang
Also filed as: ZHANG DONG · ZHANG DONG X · ZHANG DONG-XIAO
9 granted patents·14 pending applications·183 citations·filing 1997–2023
90Inventor score
Top patents by PatentIndex Score
23 records- 0194US6569420B2Human interferon-ε: a type I interferonGENENTECH INC·Filed 2001·Granted May 27, 2003·53 cites·15 claims
- 0284US6252051B1ErbB4 receptor-specific neuregulin related ligand antibodies and uses thereforGENENTECH INC·Filed 1998·Granted Jun 26, 2001·39 cites·4 claims
- 0384US6121415AErbB4 receptor-specific neuregolin related ligands and uses thereforGENENTECH INC·Filed 1997·Granted Sep 19, 2000·38 cites·7 claims
- 0479US7846453B2Methods of stimulating ErbB4 receptor phosphorylationGENENTECH INC·Filed 2006·Granted Dec 7, 2010·2 cites·6 claims
- 0578US6200780B1Human interferon-ε(IFN-ε), a type I interferonGENENTECH INC·Filed 1998·Granted Mar 13, 2001·20 cites·22 claims
- 0670US2008096215A1Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2007·Application pending·0 cites
- 0767US2005164250A1Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2004·Application pending·0 cites
- 0865US7662585B2ErbB4 receptor-specific neuregulin related ligands and uses thereforGENENTECH INC·Filed 2004·Granted Feb 16, 2010·0 cites·13 claims
- 0964US2003185800A1Human interferon-epsilon: a type I interferonGENENTECH INC·Filed 2003·Application pending·0 cites
- 1062US6299877B1Type I interferonsGENENTECH INC·Filed 1998·Granted Oct 9, 2001·15 cites·13 claims
- 1158US6299869B1Human interferon-epsilon: a type I interferonGENENTECH INC·Filed 1998·Granted Oct 9, 2001·12 cites·25 claims
- 1258US2005136467A1ErbB4 receptor-specific neuregulin related ligands and uses thereforGENENTECH INC·Filed 2005·Application pending·0 cites
- 1356US2006051351A1ErbB4 receptor-specific neuregulin related ligands and uses thereforGENENTECH INC·Filed 2005·Application pending·0 cites
- 1455US2003036166A1ErbB4 receptor-specific neuregulin related ligands and uses thereforGENENTECH INC·Filed 2002·Application pending·0 cites
- 1555US2002082229A1ErbB4 receptor-specific neuregulin related ligands and uses thereforGENENTECH INC·Filed 2001·Application pending·0 cites
- 1654US2002161200A1ErbB4 receptor-specific neuregulin related ligands and uses thereforGENENTECH INC·Filed 2002·Application pending·0 cites
- 1752US2025368742A1Anti-mica/b antibodies and uses thereofD2M BIOTHERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1852US2002164680A1ErbB4 receptor-specific neuregulin related ligands and uses thereforGENENTECH INC·Filed 2001·Application pending·0 cites
- 1951US2025171534A1Anti-lilrb1/2 antibodies and uses thereofD2M BIOTHERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2050US6994856B1ErbB4 receptor-specific neuregulin related ligands and uses thereforGENENTECH INC·Filed 1998·Granted Feb 7, 2006·4 cites·2 claims
- 2149US2022403022A1Anti-TIGIT Antibodies and Uses ThereofMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 2248US2022073616A1Methods of administering anti-tim-3 antibodiesMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
- 2348US2022081480A1Anti-tim-3 antibodiesMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dong-Xiao Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →